Drägerwerk AG & Co. KGaA (ETR:DRW3) Given Consensus Recommendation of “Buy” by Analysts

Shares of Drägerwerk AG & Co. KGaA (ETR:DRW3) have been assigned an average recommendation of “Buy” from the six analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is €87.60 ($103.06).

Several equities analysts have recently issued reports on the stock. Nord/LB set a €103.00 ($121.18) price target on shares of Drägerwerk AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, November 5th. Warburg Research set a €103.00 ($121.18) target price on shares of Drägerwerk AG & Co. KGaA and gave the stock a “buy” rating in a research note on Thursday, January 14th. Kepler Capital Markets set a €71.00 ($83.53) price target on shares of Drägerwerk AG & Co. KGaA and gave the stock a “neutral” rating in a report on Monday, January 11th. Finally, Independent Research set a €66.00 ($77.65) price target on shares of Drägerwerk AG & Co. KGaA and gave the stock a “sell” rating in a report on Friday, January 15th.

Shares of DRW3 stock traded down €1.90 ($2.24) during trading hours on Tuesday, hitting €64.90 ($76.35). 64,820 shares of the company’s stock traded hands, compared to its average volume of 33,804. The stock’s 50 day simple moving average is €67.87 and its 200 day simple moving average is €69.35. The stock has a market cap of $558.14 million and a PE ratio of 46.23. Drägerwerk AG & Co. KGaA has a 12 month low of €47.94 ($56.40) and a 12 month high of €108.50 ($127.65). The company has a quick ratio of 0.91, a current ratio of 1.61 and a debt-to-equity ratio of 15.25.

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co KGaA operates as medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Recommended Story: What are the most popular ETFs

Analyst Recommendations for Drägerwerk AG & Co. KGaA (ETR:DRW3)

Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.